NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Neurodevelopment at 5.5 Years of Age in Children Who Received Infant Formula With Enriched Protein Fractions

CompletedN/A

Sponsor: Mead Johnson Nutrition

Conditions: Cognitive Ability, General

Interventions: Enriched Protein Fractions, Protein Fraction

Countries: China

This is a follow-up study of a multi-center, double-blind, randomized, controlled, parallel-designed, prospective trial and is intended to evaluate neurodevelopment at 5.5 years of age and health outcomes through 5.5 years of age in participants who received one of two staged study formulas through one year of age.

Eligibility overview

Sex: ALL

Age: 64 Months to 68 Months

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Participant who previously consumed study formula through one year of age in MJN Project 6027
* 5.5 years of age (i.e. when child turns 5 years and 6 months old ± 2 months) at Visit 1
* Signed informed consent obtained for child's participation in the study

Exclusion Criteria:

* No exclusion criteria

Locations (1)

Anhui, China